These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 10771257)
21. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors. Widdowson PS; Gyte AJ; Upton R; Wyatt I Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518 [TBL] [Abstract][Full Text] [Related]
22. Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation. Manganotti P; Bongiovanni LG; Zanette G; Turazzini M; Fiaschi A Epilepsia; 1999 Mar; 40(3):316-21. PubMed ID: 10080512 [TBL] [Abstract][Full Text] [Related]
23. Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats. Folbergrová J Exp Neurol; 1997 Jun; 145(2 Pt 1):442-50. PubMed ID: 9217080 [TBL] [Abstract][Full Text] [Related]
24. Ca2+ channel blockade and the antielectroshock activity of NMDA receptor antagonists, CGP 40116 and CGP 43487, in mice. Gasior M; Borowicz K; Starownik R; Kleinrok Z; Czuczwar SJ Eur J Pharmacol; 1996 Sep; 312(1):27-33. PubMed ID: 8891575 [TBL] [Abstract][Full Text] [Related]
25. Cortical epileptic afterdischarges in immature rats are differently influenced by NMDA receptor antagonists. Slamberová R; Mares P Eur J Pharmacol; 2005 May; 516(1):10-7. PubMed ID: 15904917 [TBL] [Abstract][Full Text] [Related]
26. Excitatory aminoacids and epileptic seizures in immature brain. Mares P; Folbergrová J; Kubová H Physiol Res; 2004; 53 Suppl 1():S115-24. PubMed ID: 15119942 [TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamics of the anticonvulsant effect of oxazepam in aging BN/BiRij rats. Stijnen AM; Postel-Westra I; Langemeijer MW; Hoogerkamp A; Voskuyl RA; van Bezooijen CF; Danhof M Br J Pharmacol; 1992 Sep; 107(1):165-70. PubMed ID: 1330159 [TBL] [Abstract][Full Text] [Related]
28. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine. Witkin JM; Gasior M; Heifets B; Tortella FC J Pharmacol Exp Ther; 1999 May; 289(2):703-11. PubMed ID: 10215643 [TBL] [Abstract][Full Text] [Related]
29. Postnatal challenge dose of methamphetamine amplifies anticonvulsant effects of prenatal methamphetamine exposure on epileptiform activity induced by electrical stimulation in adult male rats. Bernášková K; Matějovská I; Slamberová R Exp Neurol; 2011 Jun; 229(2):282-7. PubMed ID: 21349271 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic/pharmacodynamic relationship of benzodiazepines in the direct cortical stimulation model of anticonvulsant effect. Hoogerkamp A; Arends RH; Bomers AM; Mandema JW; Voskuyl RA; Danhof M J Pharmacol Exp Ther; 1996 Nov; 279(2):803-12. PubMed ID: 8930187 [TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat. Jonker DM; Voskuyl RA; Danhof M Epilepsia; 2004 May; 45(5):424-35. PubMed ID: 15101823 [TBL] [Abstract][Full Text] [Related]
32. Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats. Mares P; Mikulecká A Epilepsy Behav; 2009 Jan; 14(1):32-9. PubMed ID: 18786655 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic-pharmacodynamic modelling in pre-clinical investigations: principles and perspectives. Danhof M; Mandema JW; Hoogerkamp A; Mathôt RA Eur J Drug Metab Pharmacokinet; 1993; 18(1):41-7. PubMed ID: 8335038 [TBL] [Abstract][Full Text] [Related]
34. Ketamine increases human motor cortex excitability to transcranial magnetic stimulation. Di Lazzaro V; Oliviero A; Profice P; Pennisi MA; Pilato F; Zito G; Dileone M; Nicoletti R; Pasqualetti P; Tonali PA J Physiol; 2003 Mar; 547(Pt 2):485-96. PubMed ID: 12562932 [TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamic and pharmacokinetic interaction studies of loreclezole with felbamate, lamotrigine, topiramate, and oxcarbazepine in the mouse maximal electroshock seizure model. Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ Epilepsia; 2005 Mar; 46(3):344-55. PubMed ID: 15730531 [TBL] [Abstract][Full Text] [Related]
36. Effects of calcium channel blockers on behaviors induced by the N-methyl-D-aspartate receptor antagonist, dizocilpine, in rats. Sukhotina IA; Dravolina OA; Medvedev IO; Bespalov AY Pharmacol Biochem Behav; 1999 Aug; 63(4):569-80. PubMed ID: 10462185 [TBL] [Abstract][Full Text] [Related]
37. Low dose of bupropion significantly enhances the anticonvulsant activity of felbamate, lamotrigine and topiramate in mice. Barczyński B; Buszewicz G; Łuszczki JJ; Bańka K; Tutaj K; Mróz T; Wielosz M; Mądro R; Tutka P Eur J Pharmacol; 2011 Jan; 650(2-3):550-5. PubMed ID: 21034737 [TBL] [Abstract][Full Text] [Related]
38. Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics. Metcalf CS; Klein BD; McDougle DR; Zhang L; Kaufmann D; Bulaj G; White HS Epilepsia; 2017 Feb; 58(2):239-246. PubMed ID: 28098336 [TBL] [Abstract][Full Text] [Related]
39. Modulation of seizure threshold by vagus nerve stimulation in an animal model for motor seizures. De Herdt V; De Waele J; Raedt R; Wyckhuys T; El Tahry R; Vonck K; Wadman W; Boon P Acta Neurol Scand; 2010 Apr; 121(4):271-6. PubMed ID: 20003088 [TBL] [Abstract][Full Text] [Related]
40. Newer anticonvulsant drugs: role of pharmacology, drug interactions and adverse reactions in drug choice. Natsch S; Hekster YA; Keyser A; Deckers CL; Meinardi H; Renier WO Drug Saf; 1997 Oct; 17(4):228-40. PubMed ID: 9352959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]